HYDRALAZINE HYDROCHLORIDE Drug Patent Profile

Which patents cover Hydralazine Hydrochloride, and when can generic versions of Hydralazine Hydrochloride launch?

Hydralazine Hydrochloride is a drug marketed by Abraxis Pharm, Am Regent, Baxter Hlthcare Corp, Eugia Pharma, Fresenius Kabi Usa, Hikma, Kindos, Navinta Llc, Pharmobedient, Rising, Smith And Nephew, Solopak, Teva Parenteral, Actavis Elizabeth, Actavis Grp Ptc, Alkem Labs Ltd, Ascot, Cadila Pharms Ltd, Chartwell Rx, Glenmark Pharms Ltd, Halsey, Heritage, Heritage Pharms Inc, Hetero Labs Ltd Iii, Impax Labs, Invagen Pharms, Ivax Sub Teva Pharms, Macleods Pharms Ltd, Mutual Pharm, Pliva, Purepac Pharm, Quantum Pharmics, Sciegen Pharms, Strides Pharma, Strides Pharma Intl, Superpharm, Tp Anda Holdings, Upsher Smith Labs, Usl Pharma, Vangard, Vitarine, Watson Labs, West Ward, Solvay, Ivax Pharms, and Mylan. and is included in ninety-seven NDAs.

The generic ingredient in HYDRALAZINE HYDROCHLORIDE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.

Summary for HYDRALAZINE HYDROCHLORIDE

US Patents:	0
Applicants:	46
NDAs:	97
Finished Product Suppliers / Packagers:	44
Raw Ingredient (Bulk) Api Vendors:	1
Clinical Trials:	68
Patent Applications:	2,403
Drug Prices:	Drug price information for HYDRALAZINE HYDROCHLORIDE
DailyMed Link:	HYDRALAZINE HYDROCHLORIDE at DailyMed

See drug prices for HYDRALAZINE HYDROCHLORIDE

Recent Clinical Trials for HYDRALAZINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Tanta University	PHASE1
University of Cambridge	PHASE4
University of Abuja	PHASE4

See all HYDRALAZINE HYDROCHLORIDE clinical trials

Pharmacology for HYDRALAZINE HYDROCHLORIDE

Drug Class	Arteriolar Vasodilator
Physiological Effect	Arteriolar Vasodilation

Medical Subject Heading (MeSH) Categories for HYDRALAZINE HYDROCHLORIDE

Antihypertensive Agents

Vasodilator Agents

Anatomical Therapeutic Chemical (ATC) Classes for HYDRALAZINE HYDROCHLORIDE

C02DB	Hydrazinophthalazine derivatives
C02D	ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
C02	ANTIHYPERTENSIVES
C	Cardiovascular system

US Patents and Regulatory Information for HYDRALAZINE HYDROCHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmobedient	HYDRALAZINE HYDROCHLORIDE	hydralazine hydrochloride	TABLET;ORAL	090413-002	Dec 8, 2010		DISCN	No	No
Superpharm	HYDRALAZINE HYDROCHLORIDE	hydralazine hydrochloride	TABLET;ORAL	088787-001	Aug 28, 1984		DISCN	No	No
Halsey	HYDRALAZINE HYDROCHLORIDE	hydralazine hydrochloride	TABLET;ORAL	089178-001	Jan 15, 1986		DISCN	No	No
Chartwell Rx	HYDRALAZINE HYDROCHLORIDE	hydralazine hydrochloride	TABLET;ORAL	088848-001	Feb 26, 1985		DISCN	No	No
Rising	HYDRALAZINE HYDROCHLORIDE	hydralazine hydrochloride	TABLET;ORAL	209251-002	Jul 9, 2018		DISCN	No	No
Vangard	HYDRALAZINE HYDROCHLORIDE	hydralazine hydrochloride	TABLET;ORAL	087712-001	Approved Prior to Jan 1, 1982		DISCN	No	No